| Name | Title | Contact Details |
|---|
For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health`s commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Guided by its uniquely empathic heritage, NRC Health`s patient-focused approach, unmatched market research, and emphasis on consumer preferences are transforming the healthcare experience, creating strong outcomes for patients and entire healthcare systems. NRC Health is ranked #1 for Patient Experience Improvement in the 2023 Best in KLAS report.
IPG works with top national and regional commercial payers, as well as various manufacturers in the cardiovascular, neurological and orthopedic spaces.
Accent Biomedical is a Stow, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
obé is a premium fitness network and community that gets you results AND brings the fun. With 22 live classes per day and 5,000+ on-demand workouts available 24/7—all taught by the best instructors in NYC—our motto is: get fit, not bored. From HIIT to Pilates to Dance, Sculpt, Strength, Yoga, Pre/Postnatal, Cardio Boxing, and more, obé classes are designed to meet you wherever you are in your fitness journey.
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.